{
  "id": "63eee73ef36125a426000003",
  "type": "list",
  "question": "What causes Serpentine Supravenous Hyperpigmentation?",
  "ideal_answer": "Serpentine supravenous hyperpigmentationis a rare vasculo-cutaneous entity that has been associated with peripheral infusion of chemotherapy agents, in particular 5-fluorouracil, but also seen with docetaxel, fotemustine, and vinorelbine.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/20134385",
    "http://www.ncbi.nlm.nih.gov/pubmed/22136872",
    "http://www.ncbi.nlm.nih.gov/pubmed/1559000",
    "http://www.ncbi.nlm.nih.gov/pubmed/36448076",
    "http://www.ncbi.nlm.nih.gov/pubmed/29951170",
    "http://www.ncbi.nlm.nih.gov/pubmed/23745227",
    "http://www.ncbi.nlm.nih.gov/pubmed/31168954",
    "http://www.ncbi.nlm.nih.gov/pubmed/28878924"
  ],
  "snippets": [
    {
      "text": "Serpentine supravenous hyperpigmentation (SSH) is a unique type of chemotherapy-associated drug eruption, characterized by hyperpigmentation along the superficial venous network.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31168954",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Serpentine supravenous hyperpigmentation (SSH) is a rare vasculo-cutaneous entity that has been associated with peripheral infusion of chemotherapy agents, in particular 5-FU1-3, but also seen with docetaxel4,5, fotemustine6, and vinorelbine7. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29951170",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Serpentine supravenous hyperpigmentation is a peculiar cutaneous eruption that follows the path of vein after intravenous injection of the chemotherapeutic agent. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28878924",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Serpentine erythematous or hyperpigmented streaks along the superficial venous network proximal to the site of injection may occur as a distinctive eruption after infusion of several chemotherapeutic agents. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22136872",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Serpentine supravenous hyperpigmentation was the term coined by Hrushesky to describe increased pigmentation of the skin immediately overlying the venous network used for intravenous infusion of 5-fluorouracil. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20134385",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Two cases of serpentine supravenous hyperpigmentation developing in the area of fotemustine infusions are reported. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1559000",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The serpentine supravenous hyperpigmentation on the lower extremities was uniform in width and color, which contrasts with the darker discoloration near the site of infusion seen with PSSH associated with chemotherapy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23745227",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "5-fluorouracil, docetaxel, fotemustine, vinorelbine"
}